Quantification of Cellular Drug Biodistribution Addresses Challenges in Evaluating

biodistribution drug delivery fractional occupancy in vivo nanomedicine

Journal

Advanced therapeutics
ISSN: 2366-3987
Titre abrégé: Adv Ther (Weinh)
Pays: Germany
ID NLM: 101724632

Informations de publication

Date de publication:
Mar 2021
Historique:
entrez: 17 5 2021
pubmed: 18 5 2021
medline: 18 5 2021
Statut: ppublish

Résumé

Nanoencapsulated drug delivery to solid tumors is a promising approach to overcome pharmacokinetic limitations of therapeutic drugs. However, encapsulation leads to complex drug biodistribution and delivery making analysis of delivery efficacy challenging. As proxies, nanocarrier accumulation or total tumor drug uptake in the tumor are used to evaluate delivery. Yet, these measurements fail to assess delivery of active, released drug to the target, and thus it commonly remains unknown if drug-target occupancy has been achieved. Here, we develop an approach to evaluate the delivery of encapsulated drug to the target, where residual drug target vacancy is measured using a fluorescent drug analog.

Identifiants

pubmed: 33997266
doi: 10.1002/adtp.202000125
pmc: PMC8114878
mid: NIHMS1656595
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NCI NIH HHS
ID : R00 CA198857
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA241179
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA079443
Pays : United States

Déclaration de conflit d'intérêts

Competing interests: The authors declare no competing interests.

Références

Semin Oncol. 2004 Dec;31(6 Suppl 13):106-46
pubmed: 15717740
Mol Pharm. 2011 Aug 1;8(4):1292-302
pubmed: 21630681
Mol Cancer Ther. 2017 Jul;16(7):1279-1289
pubmed: 28500233
J Control Release. 2012 Dec 10;164(2):115-24
pubmed: 22484196
Chem Biol. 1996 Dec;3(12):1021-31
pubmed: 9000007
Chem Rev. 2015 Oct 14;115(19):11147-90
pubmed: 26088284
Angew Chem Int Ed Engl. 2017 Jun 6;56(24):6927-6931
pubmed: 28485901
Sci Transl Med. 2014 Nov 5;6(261):261ra152
pubmed: 25378644
Nat Nanotechnol. 2007 Dec;2(12):751-60
pubmed: 18654426
Front Oncol. 2019 May 10;9:353
pubmed: 31134152
Clin Cancer Res. 2013 Sep 15;19(18):5003-15
pubmed: 23881923
Cancer Res. 2012 Nov 1;72(21):5588-99
pubmed: 23118055
J Control Release. 2016 Jun 28;232:255-64
pubmed: 27108612
J Control Release. 2015 Dec 28;220(Pt A):169-174
pubmed: 26596375
Science. 2014 Jan 3;343(6166):84-87
pubmed: 24336571
Nat Commun. 2014 May 28;5:3946
pubmed: 24867710
Chem Rev. 2015 Oct 14;115(19):10938-66
pubmed: 26010257
Biomaterials. 2014 Feb;35(7):2264-71
pubmed: 24360576
Proc Natl Acad Sci U S A. 2018 Nov 27;115(48):E11406-E11414
pubmed: 30429313
J Control Release. 2015 Feb 28;200:138-57
pubmed: 25545217
Nature. 2005 Apr 14;434(7035):917-21
pubmed: 15829967
Anal Chem. 2011 Aug 15;83(16):6237-44
pubmed: 21692511
J Clin Oncol. 2005 Nov 1;23(31):7794-803
pubmed: 16172456
Theranostics. 2019 Aug 14;9(21):6224-6238
pubmed: 31534547
Nat Commun. 2018 Apr 12;9(1):1410
pubmed: 29650952
Biomed Opt Express. 2014 May 01;5(6):1731-43
pubmed: 24940536
Nat Chem Biol. 2017 Feb;13(2):168-173
pubmed: 27918558
Bioconjug Chem. 2020 Mar 18;31(3):436-447
pubmed: 31922742
Cancer Res. 1986 Dec;46(12 Pt 1):6387-92
pubmed: 2946403
Nature. 2005 Apr 14;434(7035):913-7
pubmed: 15829966
Bioconjug Chem. 2015 Aug 19;26(8):1513-8
pubmed: 26017814
Methods Mol Biol. 2018;1682:223-239
pubmed: 29039106
Nat Methods. 2014 Aug;11(8):783-784
pubmed: 25075903
Nano Today. 2012 Dec 1;7(6):606-618
pubmed: 23243460
ACS Chem Biol. 2020 Jan 17;15(1):151-157
pubmed: 31809013
ACS Nano. 2018 Jul 24;12(7):6458-6468
pubmed: 29920064
Sci Transl Med. 2012 Apr 4;4(128):128ra39
pubmed: 22491949
Ann Oncol. 2004 Mar;15(3):440-9
pubmed: 14998846
J Med Chem. 2019 Oct 24;62(20):9236-9245
pubmed: 31469566
Nat Rev Clin Oncol. 2010 Nov;7(11):653-64
pubmed: 20838415
Theranostics. 2019 Oct 15;9(25):7714-7729
pubmed: 31695796
Chem Commun (Camb). 2015 Feb 18;51(14):2756-67
pubmed: 26829150
Cancer Discov. 2017 Jun;7(6):620-629
pubmed: 28242752
Adv Drug Deliv Rev. 2017 Apr;113:61-86
pubmed: 27266447
Mol Pharm. 2016 Feb 1;13(2):534-44
pubmed: 26713599
Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):1850-5
pubmed: 21233423
Nat Nanotechnol. 2017 Jan;12(1):81-89
pubmed: 27618255
Nat Biomed Eng. 2018 Aug;2(8):578-588
pubmed: 31015631
Adv Drug Deliv Rev. 2013 Jan;65(1):71-9
pubmed: 23088862
Chem Soc Rev. 2017 Jul 17;46(14):4218-4244
pubmed: 28585944
Nat Commun. 2015 Oct 27;6:8692
pubmed: 26503691
ACS Nano. 2013 Jul 23;7(7):5675-83
pubmed: 23697579
N Engl J Med. 2018 Aug 23;379(8):753-763
pubmed: 30110579
Nat Commun. 2013;4:1504
pubmed: 23422672
Cytometry A. 2020 May;97(5):528-539
pubmed: 31423731
Nature. 2016 Dec 1;540(7631):144-149
pubmed: 27851729

Auteurs

Christopher B Rodell (CB)

Center for Systems Biology, Massachusetts General Hospital, Boston, MA.
School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, PA.

Paige Baldwin (P)

Department of Bioengineering, Northeastern University, Boston, MA.

Bianca Fernandez (B)

Center for Systems Biology, Massachusetts General Hospital, Boston, MA.
Institute for Innovation in Imaging, Massachusetts General Hospital, Boston, MA.

Ralph Weissleder (R)

Center for Systems Biology, Massachusetts General Hospital, Boston, MA.
Department of Systems Biology, Harvard Medical School, Boston, MA.

Srinivas Sridhar (S)

Department of Bioengineering, Northeastern University, Boston, MA.
Department of Physics, Northeastern University, Boston, MA.

J Matthew Dubach (JM)

Center for Systems Biology, Massachusetts General Hospital, Boston, MA.
Institute for Innovation in Imaging, Massachusetts General Hospital, Boston, MA.

Classifications MeSH